APOL1 Mediated Kidney Disease
Research Grant
Administered By
Duke Molecular Physiology Institute
Awarded By
Alnylam Pharmaceuticals, Inc.
Start Date
January 29, 2026
End Date
February 28, 2027
Administered By
Duke Molecular Physiology Institute
Awarded By
Alnylam Pharmaceuticals, Inc.
Start Date
January 29, 2026
End Date
February 28, 2027